Advertisement

Topics

Faber Maunsell - Bristol Company Profile

10:39 EST 17th December 2018 | BioPortfolio

Faber Maunsell operates in the fields of building, transportation and environmental engineering consulting. With a broad range of skills and disciplines, we provide technical excellence across the full service spectrum, from strategic consultancy at the highest level to practical design, implementation and asset management.In essence, we help to design the built environment for the future. Every day, Faber Maunsell professionals use their expertise to develop bridges, tunnels, railways, roads, office buildings, leisure facilities, water distribution systems, laboratories, retail parks and transport networks, all of which play a central role in any nation's economy.In the UK and Europe, we employ over 2,500 people through a network of over 30 office locations. We are part of the AECOM Technology Corporation, a leading worldwide provider of professional technical services. AECOM, through its operating companies, collectively provides a full range of financial and technical resources, which are now deployed through 24,000 employees in over 60 countries around the world.

Location

Bush House Prince Street
Bristol
Somerset
BS1 4QD
United Kingdom

Contact

Phone: 44.(0)117.901.7000
Email: enquiries@fabermaunsell.com


News Articles [390 Associated News Articles listed on BioPortfolio]

Rare-Disease Hackathon Leads to $3M for Health Data Startup RDMD

When tech entrepreneur Onno Faber learned he had an extremely rare genetic disease with no available treatments, he leaned on his tech skills and organized a Silicon Valley “hackathon” in ...

New IVF NHS clinic opens in Bristol meaning patients no longer need to travel to Cardiff – Bristol Live

Bristol LiveNew IVF NHS clinic opens in Bristol meaning patients no longer need to travel to CardiffBristol LiveCouples struggling to conceive will no longer have to travel to Cardiff for NHS IVF trea...

Investigation after claims Bristol hospital ‘covered up’ baby boy’s death – Bristol Live

Bristol LiveInvestigation after claims Bristol hospital 'covered up' baby boy's deathBristol LiveA Bristol NHS Trust has launched an investigation following claims staff at a city hospital attempted t...

Bristol-Myers Squibb Awards “Golden Tickets” to ReviveMed and Strand Therapeutics

Bristol-Myers Squibb and LabCentral, a Cambridge, Mass.-based shared laboratory space, announced the two winners of the Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral. Due to being a plat...

Bogus cosmetic surgeon used ‘fake Botox’ from China on Bristol grandmother – Bristol Live

Bristol LiveBogus cosmetic surgeon used 'fake Botox' from China on Bristol grandmotherBristol LiveA bogus cosmetic surgeon who used 'fake Botox' on a Bristol grandmother has been jailed for four years...

Bristol Promotes Christopher Boerner to Chief Commercial Officer

Bristol-Myers Squibb (NYSE: BMY) has promoted Christopher Boerner to chief commercial officer. Boerner had been head of Bristol’s U.S. commercial organization, a post he has held since joining the N...

New €10 million Parkinson's study

(University of Bristol) A new €10 million international trial to evaluate a new model of care that aims to improve the quality of life for people living with Parkinson's disease will be conducted wit...

Novo Nordisk acquires Bristol, UK─based Ziylo for $800 million

Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin─out company based at Unit DX science incubator in Bristol, UK. Ziylo has been pioneering the use of its platform te...

PubMed Articles [111 Associated PubMed Articles listed on BioPortfolio]

Positive FABER distance test is associated with higher alpha angle in symptomatic patients.

The purpose of this study was to determine the diagnostic value of the flexion abduction external rotation (FABER) distance test (FDT) for the diagnosis of cam-type femoroacetabular impingement (FAI) ...

Barking mad: The vocalisation of the John Dory, Zeus faber.

Studies on the behavioural function of sounds are very rare within heterospecific interactions. John Dory (Zeus faber) is a solitary, predatory fish that produces sound when captured, but has not been...

A qualitative evaluation of the appropriateness, validity, acceptability, feasibility and interpretability of the Bristol Impact of Hypermobility (BIoH) questionnaire.

The Bristol Impact of Hypermobility (BIoH) questionnaire is a condition-specific patient-reported outcome measure developed for adults with Joint Hypermobility Syndrome (JHS). It has previously demons...

Copper Toxicity in Bristol Bay Headwaters: Part 1-Acute Mortality and Ambient Water Quality Criteria in Low-Hardness Water.

The world-class Bristol Bay (Alaska) salmon fishery and vast deposits of copper and other metals in the watershed warrant further investigation into the potential toxicity of copper to salmonids under...

The role of biomaterials in overcoming barriers to regeneration in the central nervous system.

Clinical Trials [72 Associated Clinical Trials listed on BioPortfolio]

Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients

Observational study of axial spine pain and hyperflexibility. Patients will receive physical exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's hype...

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Companies [100 Associated Companies listed on BioPortfolio]

Faber Maunsell - Bristol

Faber Maunsell operates in the fields of building, transportation and environmental engineering consulting. With a broad range of skills and disciplines, we provide technical excellence across the ful...

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. Thi...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

More Information about "Faber Maunsell - Bristol" on BioPortfolio

We have published hundreds of Faber Maunsell - Bristol news stories on BioPortfolio along with dozens of Faber Maunsell - Bristol Clinical Trials and PubMed Articles about Faber Maunsell - Bristol for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Faber Maunsell - Bristol Companies in our database. You can also find out about relevant Faber Maunsell - Bristol Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record